NCT04027517: A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis. |
|
|
| Completed | 3 | 172 | RoW | JTZ-951, enarodustat, Darbepoetin Alfa, Nesp pre-filled syringe | JW Pharmaceutical | Anemia of Chronic Kidney Disease | 02/21 | 02/21 | | |
NCT06016036: SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease |
|
|
| Completed | 3 | 156 | RoW | SAL-0951, SAL-0951 group, Placebo, Placebo phase | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Renal Anemia in Non-dialysis Chronic Kidney Disease | 10/21 | 02/22 | | |
ChiCTR2000040431: A multicenter, randomized, double-blind, placebo-controlled phase III clinical study of SAL-0951 tablets in the treatment of renal anemia in non-dialysis chronic kidney disease |
|
|
| Not yet recruiting | 3 | 150 | | double-blind treatment with SAL-0951 tablets for 8 weeks, then open treatment with SAL-0951 tablets for 16 weeks ;double-blind treatment with placebo for 8 weeks, then open treatment with SAL-0951 tablets for 16 weeks | Guangdong Provincial People's Hospital; Shenzhen Salubris Pharmaceuticals Co., Ltd, Sponsor | Renal anemia | | | | |
